Akèy › Maladi ren kwonik › Tennessee › Chattanooga
Etid klinik pou Maladi ren kwonik nan Chattanooga, TN
4 etid pou Maladi ren kwonik ap chèche patisipan nan sit nan ak bò kote Chattanooga (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Study of Praliciguat in Participants With Focal Segmental Glomerulosclerosis (FSGS)
Ap rekriteFaz 2
- Investigator Site #4, Chattanooga
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
Ap rekriteFaz 3
- Research Site, Chattanooga
A Phase III Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With CKD Stage 3b and 4 (BalanceD-CKD)
Ap rekriteFaz 3
- Research Site, Chattanooga
Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease
Ap rekriteFaz 2
- Southeast Renal Research Institute, Chattanooga
Etid Maladi ren kwonik nan lòt vil
- New York City, NY17 etid
- Boston, MA15 etid
- Houston, TX15 etid
- Dallas, TX15 etid
- Philadelphia, PA15 etid
- Chicago, IL12 etid
- Orlando, FL11 etid
- Atlanta, GA10 etid
- Durham, NC9 etid
- Kansas City, MO9 etid
- San Antonio, TX8 etid
- Albuquerque, NM8 etid
Lòt etid nan Chattanooga
- Kansè Poumon ki pa ti selil11 etid
- Kansè Metastatik6 etid
- Miasteni grav6 etid
- Kansè ovè5 etid
- Dyabèt4 etid
- Maladi fwa steatotik4 etid
- Melanom4 etid
- Akidan serebral iskemi4 etid
- Kansè kolorektal4 etid
- Kansè poumon4 etid
- Ensifizans renn3 etid
- Ateroskleroz3 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.